News

EU approval for pembrolizumab plus paclitaxel ± bevacizumab for adult PD-L1 platinum-resistant recurrent ovarian carcinoma

Pesticides and cancer: A study reveals the biological mechanisms behind an environmental health risk

New research reveals dangers of ‘anti-aging’ supplements in cancer protection

ASGCR 2026: Call for proposals and Pearline Award nominations

‘‘Smart’’ drugs to fight cancer

New research reveals dangers of ‘anti-aging’ supplements in cancer protection

Genetic variants involved in rapid immune response linked to earlier breast cancer onset in BRCA1 carriers

McVie-Veronesi Award: Recognising leaders in improving cancer outcomes in LMICs - call for nominations

PSMA therapy delays hormone therapy in prostate cancer

Most detailed map to date of breast tissue changes reveals role of menopause in cancer susceptibility

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

Cell surface protein uPAR may hold the key to targeting solid tumours with car t cell therapy